Skip to main content

Advertisement

Table 3 Incidence of cardio-cerebrovascular events (/1000 persons/year) (95%CI)

From: Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes

Patients Group Total cardio-cerebrovascular events Myocardial infarction Cerebral infarction Cerebral hemorrhage
Total Diabetes 3.5 (3.37–3.78) 2.3 (2.17–2.88) 1.5 (1.37–1.78) 0.8 (0.66–0.98)
Diabetes combined with hyperlipidemia 6.4 (6.09–7.04)a 4.4 (4.11–4.91)a 3.4 (3.24–3.81)a 1.6 (1.42–1.81)a
< 65 years Diabetes 3.6 (3.57–4.18) 2.5 (2.37–2.78) 1.8 (1.68–1.96) 0.7 (0.6–0.78)
Diabetes combined with hyperlipidemia 5.2 (5.01–5.5)a 4.1 (3.8–4.21)a 1.7 (1.64–1.81) 0.6 (0.45–0.81)
≥ 65 years Diabetes 2.6 (2.47–2.88) 1.8 (1.67–1.94) 1.2 (1.08–1.36) 0.6 (0.57–0.78)
Diabetes combined with hyperlipidemia 2.8 (2.71–2.91) 1.7 (1.66–2.01) 1.3 (1.24–1.41) 0.5 (0.45–0.65)
Females Diabetes 2.5 (2.37–2.75) 1.9 (1.78–2.04) 1.1 (1.01–1.26) 0.5 (0.38–0.61)
Diabetes combined with hyperlipidemia 4.1 (4.01–4.2)a 3.1 (2.8–3.21)a 1.2 (1.04–1.31) 0.6 (0.55–0.71)
Males Diabetes 3.2 (3.13–3.4) 2.5 (2.31–2.65) 1.7 (1.57–1.88) 0.9 (0.76–1.08)
Diabetes combined with hyperlipidemia 6.1 (5.89–6.44)a 4.8 (4.61–5.2)a 2.8 (2.74–3.01)a 1.4 (1.22–1.61)a
  1. CI confidence interval
  2. Note: aP < 0.05, which is compared with the same patients in diabetes group